Sökning: "Uppsala model"
Visar resultat 11 - 15 av 2483 avhandlingar innehållade orden Uppsala model.
11. Covariate Model Building in Nonlinear Mixed Effects Models
Sammanfattning : Population pharmacokinetic-pharmacodynamic (PK-PD) models can be fitted using nonlinear mixed effects modelling (NONMEM). This is an efficient way of learning about drugs and diseases from data collected in clinical trials. LÄS MER
12. Model Checking Parameterized Timed Systems
Sammanfattning : In recent years, there has been much advancement in the area of verification of infinite-state systems. A system can have an infinite state-space due to unbounded data structures such as counters, clocks, stacks, queues, etc. It may also be infinite-state due to parameterization, i.e. LÄS MER
13. Improvement and Assessment of Two-Dimensional Resistivity Models Derived from Radiomagnetotelluric and Direct-Current Resistivity Data
Sammanfattning : Two-dimensional (2-D) models of electrical resistivity are improved by jointly inverting radiomagnetotelluric (RMT) and direct-current resistivity (DCR) data or by allowing for displacement currents in the inversion of RMT data collected on highly resistive bedrock. Uniqueness and stability of the 2-D models are assessed with a model variance and resolution analysis that allows for the non-linearity of the inverse problem. LÄS MER
14. Fragmentation in Proton-Nucleus Reactions from 100 to 1400 MeV
Sammanfattning : The heaviest fragments, recoils, have been studied in proton and deuteron induced 28Si reactions and proton-20Ne reactions at 100-300 MeV per nucleon. Inclusive charge and angular distributions and coincidences between He nuclei and recoils have been compared to two theoretical models, Dubna Cascade Model and JAERI Quantum Molecular Dynamics. LÄS MER
15. Methods for handling model misspecification in pharmacometric model-based approaches for the analysis of longitudinal clinical trial data
Sammanfattning : Pharmacometrics model-based analyses proved to be increasingly useful in drug discovery and development. This usefulness was made evident by the formalisation of the model-integrated drug discovery and development framework (MID3). LÄS MER